Floatz logo

Letrozole

Familial Adenomatous Polyposis

Yonsei UniversitySmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Familial Adenomatous Polyposis cohort.

Asset / SponsorPhaseRating
Eflornithine
Cancer Prevention Pharmaceuticals, Inc.
Phase 3BB
Eicosapentanoic Acid
S.L.A. Pharma AG
Phase 3BB
Azithromycin
Tel-Aviv Sourasky Medical Center
Phase 4BB
Dfn-15
Yonsei University
Phase 3BB
URSODEOXYCHOLIC ACID
National Cancer Institute (NCI)
Phase 2/3BB

View all 16 →

Same molecule, other indications

Letrozole is also rated in:

infertility disorderDormant
BBB
Indicative ·
79 / 100
View asset →
anovulationDormant
BBB
Indicative ·
78 / 100
View asset →
Diabetes MellitusDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →